- Home
- HSCS vs IMCC Comparison
HSCS vs IMCC Comparison
Compare HSCS & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- IMCC
- Stock Information
- Founded
- HSCS 2007
- IMCC 1980
- Country
- HSCS United States
- IMCC Israel
- Employees
- HSCS N/A
- IMCC N/A
- Industry
- HSCS Medical Specialities
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- HSCS Health Care
- IMCC Health Care
- Exchange
- HSCS Nasdaq
- IMCC Nasdaq
- Market Cap
- HSCS 9.9M
- IMCC 10.4M
- IPO Year
- HSCS 2022
- IMCC N/A
- Fundamental
- Price
- HSCS $2.97
- IMCC $1.32
- Analyst Decision
- HSCS Strong Buy
- IMCC
- Analyst Count
- HSCS 2
- IMCC 0
- Target Price
- HSCS $10.50
- IMCC N/A
- AVG Volume (30 Days)
- HSCS 32.6K
- IMCC 1.3M
- Earning Date
- HSCS 12-15-2025
- IMCC 11-13-2025
- Dividend Yield
- HSCS N/A
- IMCC N/A
- EPS Growth
- HSCS N/A
- IMCC N/A
- EPS
- HSCS N/A
- IMCC N/A
- Revenue
- HSCS $6,250.00
- IMCC $37,606,703.00
- Revenue This Year
- HSCS N/A
- IMCC $47.12
- Revenue Next Year
- HSCS N/A
- IMCC $12.83
- P/E Ratio
- HSCS N/A
- IMCC N/A
- Revenue Growth
- HSCS N/A
- IMCC 1.92
- 52 Week Low
- HSCS $2.53
- IMCC $0.93
- 52 Week High
- HSCS $6.47
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- HSCS 44.22
- IMCC 43.09
- Support Level
- HSCS $2.95
- IMCC $0.93
- Resistance Level
- HSCS $3.15
- IMCC $1.54
- Average True Range (ATR)
- HSCS 0.19
- IMCC 0.16
- MACD
- HSCS 0.03
- IMCC 0.01
- Stochastic Oscillator
- HSCS 53.62
- IMCC 60.33
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.